Study suggests current Japanese encephalitis vaccines might only provide partial protection

Written by Louise White

Japanese encephalitis (JE) is one of the world’s most frequently occurring forms of viral encephalitis. There is currently no specific treatment for the infection, which has a mortality rate of 30–35% and can cause long-term disability. At present, WHO recommends Japanese encephalitis virus (JEV) vaccination as a treatment for JE in all areas where the disease is recognized as a significant risk to public health. In a recent study published in PLoS Neglected Tropical Diseases, Guodong Liang and colleagues from the Chinese Center for Disease Control and Prevention (Beijing, China), carried out several experiments to test the efficacy of current...

To view this content, please register now for access

It's completely free